Cardiovascular magnetic resonance of cardiomyopathies

Alpendurada, Francisco; O’Hanlon, Rory; Prasad, Sanjay

doi:10.1007/s11886-009-0010-3

Cited by 7 publications

(4 citation statements)

References 51 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…3,7,10,[13][14][15][16] Contrastenhanced cardiovascular magnetic resonance (CMR) imaging with late gadolinium enhancement (LGE) is capable of noninvasive identification of myocardial fibrosis in coronary artery disease and cardiomyopathies, [17][18][19][20] including HCM. [21][22][23][24] Although recent investigations in HCM have demonstrated an association between LGE and ambulatory ventricular tachyarrhythmias, 14,[25][26][27] available data do not resolve the clinical utility of LGE in sudden death risk stratification.…”

Section: Editorial See P 455 Clinical Perspective On P 495mentioning

confidence: 99%

Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy

et al. 2014

View full text Add to dashboard Cite

M ore than 50 years after its contemporary description, hypertrophic cardiomyopathy (HCM) remains the most common cause of sudden death in the young. [1][2][3][4][5][6] Although several clinical markers have proved to be useful guides for risk stratification, 3-5,7 current strategies do not identify all HCM patients at risk for sudden death. 3,5,8,9 Over the last Background-Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden death in the young, although not all patients eligible for sudden death prevention with an implantable cardioverter-defibrillator are identified. Contrast-enhanced cardiovascular magnetic resonance with late gadolinium enhancement (LGE) has emerged as an in vivo marker of myocardial fibrosis, although its role in stratifying sudden death risk in subgroups of HCM patients remains incompletely understood. Methods and Results-We assessed the relation between LGE and cardiovascular outcomes in 1293 HCM patients referred for cardiovascular magnetic resonance and followed up for a median of 3.3 years. Sudden cardiac death (SCD) events (including appropriate defibrillator interventions) occurred in 37 patients (3%

show abstract

Section: Editorial See P 455 Clinical Perspective On P 495mentioning

confidence: 99%

Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy

et al. 2014

View full text Add to dashboard Cite

show abstract

“…Cardiovascular magnetic resonance (CMR) has been studied as an alternative to echocardiography for the diagnosis of LVNC and seems to be useful especially in patient without good echocardiographic images 20,21 …”

Section: Cardiovascular Magnetic Resonancementioning

confidence: 99%

Left Ventricular Non Compaction in Children

Weisz

Limongelli

Pacileo

et al. 2010

Congenital Heart Disease

View full text Add to dashboard Cite

Left ventricular non compaction (LVNC) is a myocardial disease characterized by a hypertrabeculated myocardium. The hypertrabeculations in the left ventricular wall define deep recesses communicating with the left ventricular chamber where blood penetrates with increased risk of blood clots in the meshwork of the prominent trabeculations. The left ventricular apex and the free wall are particularly affected. During in utero ventriculogenesis, myocardial blood supply is initially linked to the presence of sinusoids, in which blood penetrates and diffuses nutriments and oxygen to myocardial cells. Progressively, with the development of the heart and the increase of cells demand of blood, coronary arteries system develops. This step is associated with myocardial modification that leads to compaction of hypertrabeculated myocardial net. Probably, the premature interruption of this process leads to ventricular noncompaction. Many studies have been conducted in adults with hypertrabeculated myocardium. To date, data regarding childhood LVNC are sparse. The aim of this review is to summarize the clinical and preclinical knowledge about LVNC in children.

show abstract

“…• Cardiomyopathies are a heterogenous group of primary cardiac muscle disorder of genetic or non-genetic origin excluding the ischemic or CHD-related anomalies. CMR is showing great potential in the pediatric population for the diagnostic assessment and therapeutic monitoring of patients with all types of cardiomyopathies (75). Of the genetic or hereditary cardiomyopathies, the most commonly diagnosed is hypertrophic cardiomyopathy (HCM) accounting for 60% of childhood cardiomyopathies.…”

Section: Cmr Evaluation Of Acquired Heart Diseases In Childrenmentioning

confidence: 99%

Trends in pediatric cardiovascular magnetic resonance imaging

Ntsinjana

Tann

2013

Acta Radiol

View full text Add to dashboard Cite

Cardiac magnetic resonance (CMR) imaging has significantly evolved over the last decade, becoming an integral part of the contemporary assessment of both congenital and acquired pediatric heart disease. Recent trends show that there is a growing interest in clinical applications and research in this field. An attempt to discuss the evolving technologies, techniques, and applications of CMR in pediatrics is not complete without understanding the current strengths of the modality. CMR complements readily available echocardiography, in many cases information from CMR can remove the need for invasive angiographic catheterization, and in other cases can be used to augment cardiac catheterisation.

show abstract

Cardiovascular magnetic resonance of cardiomyopathies

Cited by 7 publications

References 51 publications

Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy

Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy

Left Ventricular Non Compaction in Children

Trends in pediatric cardiovascular magnetic resonance imaging

Contact Info

Product

Resources

About